单克隆抗体药物开发与市场研究

Development and Market Study of Monoclonal Antibody Medicines

下载PDF

导出

摘要对国内外单克隆抗体药物的开发与市场作了回顾与展望。主要从技术与市场等方面对单克隆抗体药物的历史。

作者周黎孙汉栋徐飞虎

机构地区杭州九源基因工程有限公司

出处《数理医药学杂志》 2004年第3期246-248,共3页 Journal of Mathematical Medicine

关键词单克隆抗体药物开发市场销售制药工业

参考文献9

1American's Pharmaceutical Manufacture Association. 371 Biotechology Medicines in Testing Promise to Bolster the Arsenal Against Disease. 2002.
2Sergey M. Kipriyanov, Fabrice Le Gall. Generation and Production of Engimeered Antibodies. Molecular biotechnology. 2004,Vol 26:39-59.
3Martin J. Glennie, Jan G.J. van de Winkel. Renaissance of cancer therapeutic antibodies. Drug Discovery Today. 2003, Vol. 8,No. 11:503-510.
4Rony Abou-Jawde, Toni Chuoeiri, Carlos Alemany, Tarek Mekhail. An Overview of Targeted Treatments in Cancer. Clinical Therapeutics. 2003,Vol. 25, No. 8:2121-2137.
5Mohit Trikha, Li Yan, Marian T Nakada. Monoclonal antibodies as therapeutics in oncology. Biotechnology. 2002,13: 609-614.
6David M. Goldenbery. Advancing role of radiolabeled antibodies in the therapy of cancer. Cancer Immunol Immunother. 2003, 52:281-296.
7Julian A. Kim, M.D. Targeted therapies for the treatment of cancer. The American Journal of Surgery. 2003,186:264-268.
8Paul Chinn, Gary Braslawsky, Christine White, Nabil Hanna.Antibody therapy of non-Hodgkin% B-Cell lymphoma. Cancer Immunol Immunother. 2003,52: 257-280.
9Mike Clark. Antibody humanization: a case of the ‘Emperor's new clothes' , special issue of Immunology Today. August 2000,1-11.

数理医药学杂志

2004年第3期

内容加载中请稍等...